The disconnect between the similar GH levels in DM vs non-DM patients and the difference in IGF-1 may also be explained by the effect of obesity [45] and hyperinsulinism both increasing hepatic GH sensitivity [46] and increasing free fatty acids, which suppress GH release [47]. Here, GH1 is linked to hyperinsulinism.